BUSINESS LIVE: Unilever boosted by price rises; AstraZeneca sales shun forecasts; BAT will complete the sale of the Russian company this year
By live commentary
published: | Updated:
Share or comment on this article:
Some links in this article may be affiliate links. If you click on it, we may earn a small commission. That helps us fund This Is Money and use it for free. We do not write articles to promote products. We do not allow any commercial relationship to compromise our editorial independence.
